Utility of serum autotaxin levels for predicting post hepatectomy liver failure in hepatocellular carcinoma

Utility of serum autotaxin levels for predicting post hepatectomy liver failure in hepatocellular carcinoma

Background/Purpose This study aimed to evaluate the usefulness of serum autotaxin, a novel liver fibrosis marker, for predicting post hepatectomy liver failure (PHLF) in patients undergoing hepatectomy for hepatocellular carcinoma (HCC). Methods Autotaxin was measured in sera from 269 patients under...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepato-biliary-pancreatic sciences 2023-06, Vol.30 (6), p.825-833
Hauptverfasser: Uemoto, Yusuke, Taura, Kojiro, Kimura, Yusuke, Yoh, Tomoaki, Nishio, Takahiro, Koyama, Yukinori, Seo, Satoru, Okazaki, Kazuyuki, Nagao, Miki, Igarashi, Koji, Hatano, Etsuro
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies
autotaxin
Hepatectomy
Hepatitis
Liver cancer
liver failure
liver fibrosis
liver resection
prediction
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background/Purpose This study aimed to evaluate the usefulness of serum autotaxin, a novel liver fibrosis marker, for predicting post hepatectomy liver failure (PHLF) in patients undergoing hepatectomy for hepatocellular carcinoma (HCC). Methods Autotaxin was measured in sera from 269 patients undergoing hepatectomy for HCC. Correlations between autotaxin level, liver fibrosis stage (METAVIR F0–F4), and PHLF, as assessed by the International Study Group of Liver Surgery criteria, were analyzed. Results Median autotaxin concentrations correlated significantly with fibrosis stage (F0, 0.93; F1, 0.96; F2, 1.18; F3, 1.40; and F4, 1.47 mg/l; P 
ISSN:1868-6974
1868-6982
DOI:10.1002/jhbp.1278